Inflammation context in Alzheimer's disease, a relationship intricate to define

C Novoa, P Salazar, P Cisternas, C Gherardelli… - Biological Research, 2022 - Springer
Abstract Alzheimer's disease (AD), the most common form of dementia, is characterized by
the accumulation of amyloid β (Aβ) and hyperphosphorylated tau protein aggregates …

Microglia-mediated synapse loss in Alzheimer's disease

L Rajendran, RC Paolicelli - Journal of Neuroscience, 2018 - Soc Neuroscience
Microglia are emerging as key players in neurodegenerative diseases, such as Alzheimer's
disease (AD). Thus far, microglia have rather been known as modulator of …

Targeting amyloidogenic processing of APP in Alzheimer's disease

J Zhao, X Liu, W Xia, Y Zhang, C Wang - Frontiers in molecular …, 2020 - frontiersin.org
Alzheimer's disease (AD) is the most common type of senile dementia, characterized by
neurofibrillary tangle and amyloid plaque in brain pathology. Major efforts in AD drug were …

The complement system: an unexpected role in synaptic pruning during development and disease

AH Stephan, BA Barres… - Annual review of …, 2012 - annualreviews.org
An unexpected role for the classical complement cascade in the elimination of central
nervous system (CNS) synapses has recently been discovered. Complement proteins are …

Alzheimer's disease, β‐amyloid, glutamate, NMDA receptors and memantine–searching for the connections

W Danysz, CG Parsons - British journal of pharmacology, 2012 - Wiley Online Library
β‐amyloid (Aβ) is widely accepted to be one of the major pathomechanisms underlying
Alzheimer's disease (AD), although there is presently lively debate regarding the relative …

[HTML][HTML] How does brain insulin resistance develop in Alzheimer's disease?

FG De Felice, MV Lourenco, ST Ferreira - Alzheimer's & Dementia, 2014 - Elsevier
Compelling preclinical and clinical evidence supports a pathophysiological connection
between Alzheimer's disease (AD) and diabetes. Altered metabolism, inflammation, and …

Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β

JM Nussbaum, S Schilling, H Cynis, A Silva… - Nature, 2012 - nature.com
Extracellular plaques of amyloid-β and intraneuronal neurofibrillary tangles made from tau
are the histopathological signatures of Alzheimer's disease. Plaques comprise amyloid-β …

Alzheimer's disease, oligomers, and inflammation

G Forloni, C Balducci - Journal of Alzheimer's Disease, 2018 - content.iospress.com
The production of soluble amyloid-β oligomers (AβOs) and the activation of inflammation are
two important early steps in the pathogenesis of Alzheimer's disease (AD). The central role …

Soluble Aβ oligomer production and toxicity

ME Larson, SE Lesné - Journal of neurochemistry, 2012 - Wiley Online Library
J. Neurochem.(2012) 120 (Suppl. 1), 125–139. Abstract For nearly 100 years following the
first description of this neurological disorder by Dr Alois Alzheimer, amyloid plaques and …

Reduced synaptic STIM2 expression and impaired store-operated calcium entry cause destabilization of mature spines in mutant presenilin mice

S Sun, H Zhang, J Liu, E Popugaeva, NJ Xu, S Feske… - Neuron, 2014 - cell.com
Mushroom dendritic spine structures are essential for memory storage, and the loss of
mushroom spines may explain memory defects in Alzheimer's disease (AD). Here we show …